Didymin Suppresses Microglia Pyroptosis and Neuroinflammation Through the Asc/Caspase-1/GSDMD Pathway Following Experimental Intracerebral Hemorrhage

Front Immunol. 2022 Jan 27:13:810582. doi: 10.3389/fimmu.2022.810582. eCollection 2022.

Abstract

Neuroinflammation has been proven to exert an important effect on brain injury after intracerebral hemorrhage (ICH). Previous studies reported that Didymin possessed anti-inflammatory properties after acute hepatic injury, hyperglycemia-induced endothelial dysfunction, and death. However, the role of Didymin in microglial pyroptosis and neuroinflammation after ICH is unclear. The current study aimed to investigate the effect of Didymin on neuroinflammation mediated by microglial pyroptosis in mouse models of ICH and shed some light on the underlying mechanisms. In this study, we observed that Didymin treatment remarkably improved neurobehavioral performance and decreased BBB disruption and brain water content. Microglial activation and neutrophil infiltration in the peri-hematoma tissue after ICH were strikingly mitigated by Didymin as well. At the molecular level, administration of Didymin significantly unregulated the expression of Rkip and downregulated the expression of pyroptotic molecules and inflammatory cytokines such as Nlrp3 inflammasome, GSDMD, caspase-1, and mature IL-1β, TNF-α, and MPO after ICH. Besides, Didymin treatment decreased the number of Caspase-1-positive microglia and GSDMD-positive microglia after ICH. Inversely, Locostatin, an Rkip-specific inhibitor, significantly abolished the anti-pyroptosis and anti-neuroinflammation effects of Didymin. Moreover, Rkip binding with Asc could interrupt the activation and assembly of the inflammasome. Mechanistically, inhibition of Caspase-1 by VX-765 attenuated brain injury and suppressed microglial pyroptosis and neuroinflammation by downregulation of GSDMD, mature IL-1β, TNF-α, and MPO based on Locostatin-treated ICH. Taken together, Didymin alleviated microglial pyroptosis and neuroinflammation, at least in part through the Asc/Caspase-1/GSDMD pathway via upregulating Rkip expression after ICH. Therefore, Didymin may be a potential agent to attenuate neuroinflammation via its anti-pyroptosis effect after ICH.

Keywords: Didymin; brain injury; intracerebral hemorrhage; microglia pyroptosis; neuroinflammation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CARD Signaling Adaptor Proteins / immunology*
  • Caspase 1 / immunology*
  • Cells, Cultured
  • Cerebral Hemorrhage
  • Flavonoids / pharmacology
  • Glycosides / pharmacology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Microglia / drug effects*
  • Microglia / immunology
  • Neuroinflammatory Diseases / drug therapy*
  • Neuroinflammatory Diseases / immunology
  • Phosphate-Binding Proteins / antagonists & inhibitors*
  • Phosphate-Binding Proteins / immunology
  • Phosphatidylethanolamine Binding Protein / immunology*
  • Pore Forming Cytotoxic Proteins / antagonists & inhibitors*
  • Pore Forming Cytotoxic Proteins / immunology

Substances

  • CARD Signaling Adaptor Proteins
  • Flavonoids
  • Glycosides
  • Gsdmd protein, mouse
  • Phosphate-Binding Proteins
  • Phosphatidylethanolamine Binding Protein
  • Pore Forming Cytotoxic Proteins
  • Pycard protein, mouse
  • Raf kinase inhibitory protein, mouse
  • didymin
  • Casp1 protein, mouse
  • Caspase 1